NOTVQ (Inotiv) EBIT per Share: $-1.42 (TTM As of Mar. 2026)


What is Inotiv EBIT per Share?

Inotiv NOTVQ -9.91% EBIT per Share is $-1.42 as of Mar. 2026. The stock has 4 warning signs investors should review. Among 169 Medical Diagnostics & Research companies, Inotiv ranks worse than 591715.38% on this metric.

Inotiv's EBIT per Share for the three months ended in Mar. 2026 was $-0.57. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.42.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Inotiv's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Inotiv was 117.30% per year. The lowest was -398.30% per year. And the median was -5.20% per year.

NOTVQ's 3-Year EBIT Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 12.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Inotiv's EBIT for the three months ended in Mar. 2026 was $-19.7 Mil.

Inotiv  (OTCPK:NOTVQ) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Inotiv EBIT per Share Related Terms

Inotiv EBIT per Share Historical Data

* Premium members only.

The historical data trend for Inotiv's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inotiv EBIT per Share Chart

Inotiv Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 -13.25 -3.17 -3.24 -0.96

Inotiv Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.15 -0.22 -0.48 -0.57

Inotiv EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Inotiv's EBIT per Share for the fiscal year that ended in Sep. 2025 is calculated as

EBIT per Share(A: Sep. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-31.175/32.452
=-0.96

Inotiv's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-19.68/34.653
=-0.57

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-1.42 mean?
Inotiv (NOTVQ) has a EBIT per Share of $-1.42 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Inotiv and its competitors. According to the industry distribution chart, Inotiv ranks #999999 out of 169 companies in the Medical Diagnostics & Research industry.
Is Inotiv's EBIT per Share too high?
Inotiv's current EBIT per Share is $-1.42. Based on the distribution chart, Inotiv ranks #999999 out of 169 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Inotiv's EBIT per Share compare to NDRA and XWEL?
According to the Medical Diagnostics & Research industry distribution chart, Inotiv ranks #999999 out of 169 companies for EBIT per Share. This places Inotiv in the lower half of its industry. The industry median EBIT per Share is 12.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 12.50, based on 169 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Inotiv and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inotiv's current EBIT per Share is $-1.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inotiv stock overvalued right now?
Based on GuruFocus' analysis, Inotiv (NOTVQ) is currently considered Possible Value Trap. The stock's GF Value™ is $1.68, compared to a current price of $0.01 — trading 99.4% below its estimated fair value. The current EBIT per Share is $-1.42. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Inotiv (NOTVQ), the current EBIT per Share is $-1.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inotiv Business Description

Other Exchanges BS50:Germany
Address 2701 Kent Avenue, West Lafayette, IN, USA, 47906
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.